Pfizer Inc. 2018 Proxy Statement

Proxy Statement Summary			1
Item 1 — Election of Directors			7
	Criteria for Board Membership		7
	Selection of Candidates		8
	Retirement Policy		8
	Our 2018 Director Nominees		8
	Director Nominees		9
Governance			16
	Overview		16
	Board Information		16
		Board Leadership Structure	16
		The Board’s Role in Risk Oversight	19
		The Board’s Oversight of Company Strategy	20
		The Board’s Role in Succession Planning	20
		Evaluating Board Effectiveness	21
		Board and Committee Information	22
		Corporate Governance Committee Report	26
		Regulatory and Compliance Committee Report	27
	Shareholder Outreach		28
	Corporate Responsibility and Sustainability		30
	Public Policy Engagement and Political Participation		31
	Pfizer Policies on Business Conduct		32
	Other Governance Practices and Policies		33
Non-Employee Director Compensation			35
	2017 Director Compensation Table		37
Securities Ownership			38
	Beneficial Owners		39
	Section 16(a) Beneficial Ownership Reporting Compliance		39
Related Person Transactions and Indemnification			40

Item 2 — Ratification of Selection of Independent Registered Public Accounting Firm		41
	Audit and Non-Audit Fees	42
Audit Committee Report		43
Item 3 — 2018 Advisory Approval of Executive Compensation		44
	Results of 2017 Advisory Vote on Executive Compensation	44
	2017 Pay for Performance	44
	2018 Advisory Vote on Executive Compensation	45
Item 4 — Approval of the Pfizer Inc. French Sub-Plan under the 2014 Stock Plan		46
Compensation Committee Report		53
Executive Compensation		54
	Compensation Discussion and Analysis	55
	Table of Contents	55
	Executive Summary	56
	Compensation Tables	85
	Financial Measures	101
Shareholder Proposals		102
	Item 5 — Right to Act by Written Consent	102
	Item 6 — Independent Chair Policy	104
	Item 7 — Report on Lobbying Activities	107
Annual Meeting Information		110
	Annual Meeting	110
	Voting	111
	Proxy Materials	113
	Other Questions	114
	Other Business	115
	Submitting Proxy Proposals and Director Nominations for the 2019 Annual Meeting	115
Annex 1 — Corporate Governance Principles		i
Annex 2 — Pfizer Inc. 2014 Stock Plan — French-Qualified Restricted Stock Unit Sub-Plan		vi

WARNING: JavaScript is disabled. CLICK HERE for help.

Table of Contents